edda has been researched along with hydrazine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
He, J; Hnatowich, DJ; Rusckowski, M; Su, ZF | 1 |
Almqvist, Y; Babaei, MH; Kairemo, K; Orlova, A; Shafii, M; Tolmachev, V | 1 |
Fröss-Baron, K; Gołkowski, F; Hubalewska-Dydejczyk, A; Huszno, B; Mikołajczak, R; Sowa-Staszczak, A | 1 |
Czepczyński, R; Gryczyńska, M; Kosowicz, J; Mikołajczak, R; Sowiński, J; Ziemnicka, K | 1 |
Biagini, SC; Blower, PJ; Dose, A; Meszaros, LK | 1 |
Avcı, CB; Durkan, K; Gündüz, C; Ozgür, A; Susluer, SY; Yurt Lambrecht, F | 1 |
Estrada, G; Ferro-Flores, G; García-Becerra, R; Gómez-Argumosa, E; Izquierdo-Sánchez, V; Ocampo-García, BE; Ortiz-Arzate, Z; Santos-Cuevas, CL | 1 |
Cabral, P; Fernandez, M; Gallazzi, F; Gambini, JP; Garcia, MF; Moreno, M; Porcal, W; Quinn, TP; Zhang, X | 1 |
Cheng, D; Li, B; Lin, QY; Meng, L; Shi, H; Tan, H; Zhang, Y | 1 |
Amirmozafari, N; Erfani, M; Mazaheri Tehrani, M | 1 |
1 trial(s) available for edda and hydrazine
Article | Year |
---|---|
Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Medullary; Edetic Acid; Female; Gastrins; Humans; Hydrazines; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Organotechnetium Compounds; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms | 2007 |
9 other study(ies) available for edda and hydrazine
Article | Year |
---|---|
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
Topics: Blood Proteins; Cells, Cultured; Edetic Acid; Endothelium, Vascular; Glycine; Humans; Hydrazines; Integrins; Ligands; Metabolic Clearance Rate; Nicotinic Acids; Oligopeptides; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Umbilical Veins | 2003 |
[99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Edetic Acid; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Hydrazines; Ligands; Metabolic Clearance Rate; Mice; Nicotinic Acids; Technetium Compounds; Tissue Distribution | 2005 |
99mTc-EDDA/HYNIC-octreotate in detection of atypical bronchial carcinoid.
Topics: Adult; Carcinoid Tumor; Edetic Acid; Female; Humans; Hydrazines; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Metastasis; Nicotinic Acids; Organotechnetium Compounds; Radiography; Radiopharmaceuticals; Somatostatin | 2007 |
Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium.
Topics: Chelating Agents; Chromatography, High Pressure Liquid; Coordination Complexes; Edetic Acid; Hydrazines; Isomerism; Mass Spectrometry; Nicotinic Acids; Technetium | 2011 |
In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Edetic Acid; Glycine; Humans; Hydrazines; Ligands; Mice; Niacinamide; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Receptors, Bombesin | 2013 |
Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Dimerization; Edetic Acid; Female; Freeze Drying; Humans; Hydrazines; Mice; Nicotinic Acids; Oligopeptides; Organotechnetium Compounds; Radiochemistry; Radiometry; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
Topics: alpha-MSH; Animals; Chelating Agents; Diagnostic Imaging; Edetic Acid; Glycine; Hydrazines; Ligands; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nicotinic Acids; Organotechnetium Compounds; Peptides; Protein Binding; Radiopharmaceuticals; Tissue Distribution | 2015 |
Preliminary application of micro-SPECT/CT imaging by
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Edetic Acid; Glycine; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Mice, Nude; Nicotinic Acids; Organotechnetium Compounds; Proto-Oncogene Proteins c-met; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2019 |
[
Topics: Animals; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Stability; Edetic Acid; Escherichia coli; Escherichia coli Infections; Hydrazines; Kidney; Mice; Nicotinic Acids; Radiopharmaceuticals; Technetium; Tissue Distribution | 2021 |